http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
NCR Atleos Certified as a Most Loved Workplace
-
American Oncology Network Achieves Success in First Performance Period of CMMI’s Enhancing Oncology Model
-
Rubrik Reveals 90% of Global IT and Security Executives Report Cyberattacks in the Past Year
-
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium
-
Innoviz Technologies Partners with Fabrinet to Launch InnovizTwo Mass Production
-
Snow Lake Launches Strategic Growth Plan Targeting Investments in Solana Crypto (SOL), and Clean Energy Technologies
-
Breaking Open the Black Box: YCharts Introduces Transparent, Customizable Risk Profiles
-
Police Federal Credit Union Selects Mahalo Banking to Deliver Next-Level Digital Engagement
-
Palvella Therapeutics (PVLA) Granted Additional U.S. Patent for QTORIN Rapamycin for the Treatment of Microcystic Lymphatic Malformations
-
Palvella Therapeutics Granted Additional U.S. Patent for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
-
BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET
-
Novocure's (NVCR) Optune Lua Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer
-
Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer
-
Elite 11 Partners with The GLD Shop to Showcase the Nation’s Top High School Quarterbacks with Exclusive Championship Chains
-
PolyPid to Participate in The Citizens Life Sciences Conference
-
Medicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
-
New Jersey Resources Highlights the Success of the Coastal Climate Initiative in Celebration of Earth Day
-
Aclaris Therapeutics (ACRS) Secures U.S. Food and Drug Administration IND Clearance for ATI-052
-
Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody
-
GENE SOLUTIONS AND ELEMENT BIOSCIENCES ENTER STRATEGIC COLLABORATION TO ADVANCE NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGY GLOBALLY
-
CitizenX Acquires Plan B Passport; Katie "The Russian" Joins Passports-for-Sale Powerhouse
-
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection
-
NNN Community RelauNNNch: A New Era Begins on Base
-
Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test
-
Allot Launches New Off-network Cybersecurity Solution, Part of its 360-degree Protection Platform
-
Board Change
-
Mercantile Bank Corporation Announces Strong First Quarter 2025 Results
-
Mercantile Bank Corporation Declares Regular Cash Dividend
-
Advance Relocation Systems Has Been Selected to Attend the 2025 AAM Annual Meeting & MuseumExpo
-
RAM Pavement Participates in the Run Jen Run 5K & Festival to Support Breast Cancer Patients
-
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages NAPCO Security Technologies, Inc. Investors to Inquire About Securities Class Action Investigation - NSSC
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fluence Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLNC
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Firsthand Technology Value Fund, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SVVC
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Everus Construction Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ECG
-
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages enCore Energy Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EU
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
Meerkat ($MERK) introduces utility-focused meme ecosystem with staking, gaming, and AI features
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages e.l.f. Beauty, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ELF
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Ready Capital Corporation Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - RC
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BigBear.ai Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBAI
-
GivBux, Inc. Finalizes Terms of Special Warrant Dividend for Shareholders - Correction
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bakkt Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BKKT
-
ATKR FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Atkore Inc. Investors to Secure Counsel Before Important April 23 Deadline in Securities Class Action - ATKR
-
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATNM
-
Greenberg Traurig's Nina D. Boyajian and Mathew S. Rosengart Named to 2025 Los Angeles Business Journal Top 100 Lawyers List
-
Global Insurance Technology Leader Guidewire to Invest $60 Million to Accelerate Insurance Innovation and Cloud Transformation in Japan
-
Salesian Missions mourns the passing of Pope Francis
-
Greenberg Traurig's Elba Gutiérrez Appointed IBA Pro Bono Committee's North American Regional Forum Liaison Officer
-
GivBux, Inc. Finalizes Terms of Special Warrant Dividend for Shareholders
